{
    "nct_id": "NCT03404791",
    "official_title": "A Multicenter Study Evaluating Safety and Efficacy of TAR-200 in Subjects With Muscle-Invasive Urothelial Carcinoma of the Bladder Who Are Ineligible for or Refuse Cisplatin-based Chemotherapy and Who Are Unfit for Radical Cystectomy",
    "inclusion_criteria": "* Histological proof of non-metastatic muscle-invasive urothelial cell carcinoma of the bladder\n* Participant must have been as fully resected as possible per the physician's judgment\n* Participants must be deemed unfit for RC due to comorbid conditions with a risk of mortality\n* Participants must refuse or be deemed ineligible for cisplatin-based chemotherapy\n* Participant must refuse or not be eligible for radiotherapy\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Other active malignancies\n* Presence of any bladder or urethral anatomic feature that in the opinion of the Investigator may prevent the safe placement, indwelling use, or removal of TAR-200\n* Pyeloureteral tube externalized to the skin (ureteral stent or unilateral nephrostomy tube is allowed)\n* Evidence of bladder perforation during diagnostic cystoscopy\n* Concurrent clinically significant infections as determined by the treating Investigator",
    "miscellaneous_criteria": ""
}